Digoxin oral solution Rx
Generic Name and Formulations:
Digoxin 0.05mg; per mL; lime-flavored; contains alcohol 10%.
Roxane Laboratories, Inc.
Indications for Digoxin oral solution:
Mild-to-moderate heart failure (with a diuretic and an ACE inhibitor when possible). Increase myocardial contractility in pediatrics with heart failure. Control of ventricular response rate in chronic atrial fibrillation.
Individualize: see full labeling. Initially 0.003mg/kg per day. Monitor digoxin levels.
Individualize: see full labeling. >2yrs: initially 0.01mg/kg per day. Monitor digoxin levels.
Renal dysfunction: reduce dose. Sinus node disease. Incomplete AV block. Accessory AV pathway (Wolff-Parkinson-White syndrome). Heart failure with preserved LV ejection fraction (eg, restrictive cardiomyopathy, constrictive pericarditis, amyloid heart disease, acute cor pulmonale, hypertrophic cardiomyopathy). Electrical cardioversion. Acute MI. Avoid in myocarditis. Toxicity risk increased by hypokalemia, hypomagnesemia, hypercalcemia, diabetes. Hypocalcemia may nullify effects. Thyroid disease. Hypermetabolic states. Monitor digoxin levels, electrolytes, renal function. Elderly. Children. Infants. Pregnancy (Cat.C). Nursing mothers.
May be potentiated by antiarrhythmics (amiodarone, propafenone, quinidine), calcium channel blockers (verapamil, diltiazem, nifedipine, nitrendipine), captopril, telmisartan, spironolactone, carvedilol, epoprostenol, diclofenac, indomethacin, cyclosporine, ketoconazole, itraconazole, rabeprazole, clarithromycin. May be antagonized by rifampin, acarbose, miglitol, colestipol, St. John's Wort, albuterol. Increased risk of arrhythmias with sympathomimetics. Others (see full labeling).
GI upset, anorexia, CNS effects (eg, blurred or yellow vision, or mental disturbances, confusion, headache, weakness, dizziness, apathy), gynecomastia, rash, heart block, arrhythmias (esp. children).
Endocrinology Advisor Articles
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Nivolumab Associated With Thyroiditis in Patients With Cancer
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Gender-Related Association Between Physical Activity, Psychological Status in T2D
- Adverse Neurodevelopmental and Mental Health Outcomes in PCOS
- HbA1c Variability Predicts All-Cause Mortality in Type 2 Diabetes
- Choroidal Thickness Changes in Patients With Untreated Diabetes
- Pre-Pregnancy Fitness Lowers Gestational Diabetes Risk